NasdaqGS - Nasdaq Real Time Price USD

Inari Medical, Inc. (NARI)

Compare
43.68 -0.16 (-0.36%)
At close: September 20 at 4:00 PM EDT
43.40 -0.28 (-0.64%)
After hours: September 20 at 7:03 PM EDT
Loading Chart for NARI
DELL
  • Previous Close 43.84
  • Open 43.97
  • Bid 31.18 x 200
  • Ask 43.79 x 400
  • Day's Range 42.76 - 44.28
  • 52 Week Range 36.73 - 69.40
  • Volume 1,215,297
  • Avg. Volume 883,468
  • Market Cap (intraday) 2.545B
  • Beta (5Y Monthly) 1.00
  • PE Ratio (TTM) --
  • EPS (TTM) -0.99
  • Earnings Date Oct 30, 2024 - Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 64.93

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

www.inarimedical.com

1,300

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NARI

View More

Performance Overview: NARI

Trailing total returns as of 9/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NARI
32.72%
S&P 500
19.55%

1-Year Return

NARI
34.75%
S&P 500
28.32%

3-Year Return

NARI
45.69%
S&P 500
28.64%

5-Year Return

NARI
5.76%
S&P 500
92.95%

Compare To: NARI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NARI

View More

Valuation Measures

Annual
As of 9/20/2024
  • Market Cap

    2.54B

  • Enterprise Value

    2.47B

  • Trailing P/E

    --

  • Forward P/E

    208.33

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.61

  • Price/Book (mrq)

    6.00

  • Enterprise Value/Revenue

    4.51

  • Enterprise Value/EBITDA

    1.58k

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -10.42%

  • Return on Assets (ttm)

    -2.14%

  • Return on Equity (ttm)

    -13.28%

  • Revenue (ttm)

    547.47M

  • Net Income Avi to Common (ttm)

    -57.05M

  • Diluted EPS (ttm)

    -0.99

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    109.67M

  • Total Debt/Equity (mrq)

    7.82%

  • Levered Free Cash Flow (ttm)

    84.18M

Research Analysis: NARI

View More

Company Insights: NARI

Research Reports: NARI

View More

People Also Watch